Thoracentesis for Heart Failure

(DRAIN-IT Trial)

This trial explores whether thoracentesis, a procedure that removes fluid from around the lungs, can reduce shortness of breath in people with congestive heart failure. Researchers compare this procedure with standard medical treatments to determine which better alleviates breathing difficulties. Suitable participants have heart failure with fluid around their lungs visible on an X-ray and symptoms such as swelling in their legs or abdomen. As an unphased trial, this study provides an opportunity to contribute to medical knowledge and potentially find symptom relief.

The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your usual medical therapy, as the study compares thoracentesis with medical therapy to medical therapy alone.

Research has shown that thoracentesis, a procedure to remove fluid from around the lungs, presents mixed safety results for people with heart failure. Some studies found that patients undergoing this procedure while hospitalized for heart failure experienced higher rates of death and complications. About one in four patients reported minor issues like pain or discomfort, though these were generally not severe.

Unlike standard treatments for heart failure, which typically involve medications such as ACE inhibitors, beta-blockers, and diuretics, thoracentesis offers a unique approach by directly removing excess fluid from around the lungs. This can provide rapid relief from symptoms like shortness of breath that are often seen in heart failure patients. Researchers are excited about thoracentesis because it could offer quicker symptomatic relief compared to traditional methods, potentially improving patients’ quality of life with fewer systemic side effects.

This trial will compare thoracentesis combined with medical therapy to medical therapy alone for heart failure patients. Research has shown that thoracentesis, a procedure to remove fluid from around the lungs, is often used for heart failure patients with fluid buildup. However, studies have found that thoracentesis does not significantly improve shortness of breath or other health outcomes for patients with sudden heart failure. For instance, one trial found no major benefits of thoracentesis compared to standard medical treatment alone. Another study showed no improvement in short-term outcomes like hospital stay length or quality of life. Overall, current evidence suggests that thoracentesis may not provide additional relief for symptoms in heart failure patients.¹²⁴⁵⁶